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ABSTRACT
HALOGENATION ENZYMES IN BACTERIA ASSOCIATED WITH THE REDBANDED ACORN WORM, PTYCHODERA JAMAICENSIS
by
Milena M. Lilles

Organohalogens have diverse biological functions in the environment. Marine
acorn worms produce brominated products that may act as antifoulants, chemical
deterrents, and substrates in bioluminescence reactions. Haloperoxidases purified from
the homogenates of acorn worms synthesize bromophenols. Commensal or mutualistic
bacteria living on the worms may produce halogenation enzymes that brominate organics.
The genomic DNA of 48 bacterial isolates from the surface of the red-banded
acorn worm, Ptychodera jamaicensis, was extracted and screened for bromoperoxidase
and FADH2-dependent halogenase genes. A 16S rDNA phylogenetic tree showed that
the isolates were gram-positive bacteria and included 36 Firmicutes and 12
Actinobacteria. Nineteen isolates had a 700 base-pair bromoperoxidase gene, and two
isolates had a 1,000 base-pair FADH2-dependent halogenase gene.
Eight of the 19 isolates positive for the bromoperoxidase gene were tested for
bromoperoxidase activity with a phenol red and monochlorodimedone assay. One isolate
had the bromoperoxidase gene and bromoperoxidase activity of 0.417 in the
monochlorodimedone assay. It is possible that bacteria on the red-banded acorn worm
synthesize bromoperoxidases, which produce bromophenols. These bacteria may
synthesize these compounds as antimicrobials towards gram-negative bacteria.
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PREFACE

The following thesis is presented as two journal articles. Chapter 1 is a literature
review of research on haloperoxidase and FADH2-dependent halogenase enzymes and
their organohalogen production. Chapter 2 presents research on cofactor-free
bromoperoxidase and FADH2-dependent halogenase genes from bacteria associated with
the red-banded acorn worm, Ptychodera jamaicensis. Bromoperoxidase activity from
eight bacterial isolates with the cofactor-free bromoperoxidase gene was also examined.

xi
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Introduction
Organohalogens are diverse compounds produced through biotic and abiotic
processes. Brominated compounds are prevalent in marine environments, while
chlorinated compounds are widespread in terrestrial sources (1). Organohalogens have
various biological functions, for instance, as pheromones, growth hormones (2, 3),
antibiotics (4, 5), and chemical deterrents (6, 7). Two of the main enzyme families
responsible for the production of these compounds are the haloperoxidases and reduced
flavin adenine dinucleotide (FADH2) -dependent halogenases. Haloperoxidases produce
the chlorinated antibiotic caldariomycin and antimicrobial brominated heptanones (8, 9).
The FADH2-dependent halogenases generate many halogenated antibiotics, including 7chlorotetracycline, chloramphenicol, pyrrolnitrin, pyoluteorin, balhimycin,
pyrroindomycin B, thienodolin, and clorobiocin (10-19). The isolation and
characterization of these enzymes may assist with the discovery and development of new
pharmaceuticals. They also have potential uses as catalysts in green chemistry processes.
There are several different types of haloperoxidase enzymes. The enzymes are
designated by the most electronegative halide they oxidize, and their cofactor
requirement. The chloroperoxidases oxidize chloride, bromide, and iodide. The
bromoperoxidases oxidize bromide and iodide, and iodoperoxidases oxidize iodide. The
heme and vanadium haloperoxidases require the transition metals heme and vanadium as
cofactors. The cofactor-free haloperoxidases or perhydrolase enzymes do not require any
metal cofactor. The reaction mechanism of the heme and vanadium haloperoxidases
differs from the cofactor-free haloperoxidases. The heme and vanadium haloperoxidases
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form oxidized halogen intermediates, mainly in the form of hypohalous acids, through the
dismutation of hydrogen peroxide (20). The hypohalous acids can act as halogenating
agents that leave the enzyme active site to halogenate a broad variety of electron rich
organic substrates. The hypohalous acids can also stay within the active site of the
enzyme and halogenate specific substrates (21). In addition, some vanadium
haloperoxidases have specific substrates. Conversely, the cofactor-free haloperoxidases
catalyze halogenations through the reversible formation of peracids from organic acids
and hydrogen peroxide (22).
The FADH2-dependent halogenases are known for halogenating specific
substrates selectively. In fact, FADH2-dependent halogenase genes are identified in most
gene clusters coding for enzymes involved in the production of halogenated metabolites,
including halogenated antibiotics and antitumor compounds (23). The halogenation
reaction requires flavin adenine dinucleotide (FAD), nicotinamide adenine dinucleotide
(NADH) or nicotinamide adenine dinucleotide phosphate (NADPH), a flavin reductase,
halide ions, and oxygen. The reaction mechanism is dependent on oxygen and may result
in the formation of flavin hydroperoxide. This intermediate could activate aromatic rings
and form oxidized intermediates that halogenate substrates. The vanadium
haloperoxidases and FADH2-dependent halogenases catalyze the production of most of
the halogenated pharmaceuticals found in the environment.
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Heme Haloperoxidases
The heme haloperoxidases are ubiquitous. These enzymes are present in
vertebrates, invertebrates, fungi, algae, protozoans, and bacteria (Table 1). The heme
haloperoxidases require appropriate halides, hydrogen peroxide, and use a range of
organic substrates in the halogenation reaction. The mechanism involves the reduction of
hydrogen peroxide to water, with the oxidation of the cofactor heme-Fe (III) to heme-Fe
(IV)=O. This oxidized cofactor reacts with a halide (X) and proton (H) to form the
oxidized enzyme intermediate, heme-Fe (III)-OXH. The resulting hypohalous acid
(OXH) produced can break from the enzyme and freely halogenate substrates (24). It is
unclear whether this is the principal reaction mechanism due to the difficulty of isolating
specific halogenating agents. Hypohalous acids, elemental halogens, and halogen-ion
intermediates can be used as halogenating agents. Representative heme haloperoxidases
in animals, fungi, algae, and bacteria are described in Table 1.
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Table 1. Representative Heme Haloperoxidase Reactions.
Enzyme & Species
Animals
Myeloperoxidase
Homo sapiens
Eosinophil peroxidase
Homo sapiens
Thyroid peroxidase
Homo sapiens
Chloroperoxidase
Notomastus lobatus
Fungi

Substrate

Organohalogens

tyrosyl residues chlorotyrosine (25)
3-chlorotyrosine (26)
tyrosyl residues 3-bromotyrosine (26)
tyrosine,
Thyroglobulin
phenol

Chloroperoxidase
β-ketoadipate
Caldariomycin fumago
tyrosine

Bacteria
Bromoperoxidase
Streptomyces
phaeochromogenes
Bromoperoxidasecatalase
Streptomyces
venezuelae

4-bromophenol, 2,4-dibromophenol
2,4,6-tribromophenol (28)
δ-chlorolevulinic acid (29)
mono and di (chloro, bromo, iodo)
tyrosines (30)
2,2-dichloro-1, 3-cyclopentanedione
(8)

2-chloro-1,
3-cyclo
pentanedione
Algae
Bromoperoxidase
Bonnemaisonia
hamifera
Bromoperoxidase
Penicillus capitatus

thyroxine (27)

3-oxooctanoic
acid
3-oxooctanoic
acid

dibromomethane
bromoform
1-pentyl bromide (31)
1-bromo-2-heptanone,
1,1-di-bromo-2-heptanone,
1,1,1-tribromo-2-heptanone (9)

pyrrolnitrin

2-bromo-pyrrolnitrin (32)

1-methyl-2pyrrole

brominated 1-methyl-2-pyrrole (33)
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Myeloperoxidase, eosinophil peroxidase and thyroid peroxidase are heme
haloperoxidases in the human body that halogenate tyrosyl residues and tyrosine as
common substrates. The end products of the myeloperoxidase and eosinophil peroxidase
reactions are hypohalous acids, not organohalogens. Hypohalous acids have biocidal
activity targeting microorganisms invading the immune system. Myeloperoxidase forms
hypochlorous acid from the respiratory burst of neutrophils, while eosinophil peroxidase
generates hypobromous acid during eosinophil degranulation. Both enzymes are capable
of halogenating tyrosyl residues in proteins, but their primary purpose appears to be
immune system support (25, 26). In contrast, thyroid peroxidase produces the
predominant organohalogen of the human body, the thyroid hormone 3,5,3’,5’tetraiodothyronine or thyroxine. Thyroid peroxidase oxidizes iodide to iodine, which
halogenates tyrosine to generate thyroxine (27). Thyroxine is responsible for stimulating
the consumption of oxygen in the body and increasing metabolism.
Marine acorn worms synthesize several types of volatile organohalogens. At least
eleven species of hemichordate worms produce brominated and chlorinated compounds
including bromophenols, bromopyrroles, bromo- and chloroindoles,
bromohydroquinones, and bromo-cyclohexanes (34, 35). The first heme haloperoxidase
isolated from a marine acorn worm was a chloroperoxidase from Notomastus lobatus.
This chloroperoxidase catalyzes the bromination of phenol producing 4-bromophenol,
2,4-dibromophenol and 2,4,6-tribromophenol (28). These brominated phenols are
naturally concentrated around the tail region of the worm. The chloroperoxidase
accounts for about 0.7% of the total soluble protein in crude extracts and requires a
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flavoprotein for activity. Similar haloperoxidase activity in the homogenates of the
marine invertebrates Thelepus setosus and Ptychodera flava laysanica catalyze the
bromination of p-hydroxybenzyl alcohol (36).
The bromophenols from acorn worms may act as negative allelochemicals to
other organisms and possibly as substrates in bioluminescent reactions. A common
function of invertebrate organohalogen production is chemical defense (1). The noxious
organohalogens are concentrated near the tail of the worms and at the opening of acorn
worm burrows so that they are the first compounds encountered. Some of the
halogenated products isolated from these worms are 3-haloindoles from the genera
Ptychodera and Glossobalanus and bromophenols from the genus Balanoglossus (37).
These organohalogens are responsible for the characteristic iodoform odor of the worms
and negatively affect some non-organohalogen producing polychaetes and juvenile
bivalves from settling close to contaminated burrows (7, 38). Although the
halometabolites do not directly ward off predators, they appear to protect acorn worm
settlements from encroaching organisms.
The worms belonging to the genera Ptychodera, Glossobalanus, and
Balanoglossus have bioluminescent capabilities (39). A luciferin and luciferase isolated
from Balanoglossus biminiensis extracts displayed a blue-green luminescence upon the
addition of hydrogen peroxide (40). The purified luciferin had an iodoform odor, as does
2,6-dibromophenol, the primary halogenated product isolated from B. biminiensis (41).
B. biminiensis may produce 2,6-dibromophenol as a luciferin in bioluminescence
reactions. Luciferins are small molecules that are utilized by luciferase to produce energy
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in the form of light. The structure of the luciferin from B. bimineiensis has not been
elucidated, but Cormier and Dure suggest that the luciferase is a peroxidase (40). More
recently, a luminous compound 2,3,5,6- tetrabromohydroquinone (TBHQ), isolated from
the acorn worm Ptychodera flava, displays green fluorescence when reacted with
riboflavin, hydrogen peroxide, and horseradish peroxidase (42). Organohalogens and
heme haloperoxidases may play a role in bioluminescent reactions.
The fungi produce many halogenated compounds of pharmaceutical interest (43).
The first heme haloperoxidase isolated was from the fungus Caldariomyces fumago, and
produces the chlorinated antibiotic caldariomycin. This extracellular chloroperoxidase
chlorinates β-keto acids, cyclic β-diketones, tyrosine, and substituted phenols (29, 30).
In particular, the chloroperoxidase chlorinates 1,3-cylcopentanedione and 2-chloro-1, 3cyclopentanedione to the caldariomycin intermediate, 2,2-dichloro-1, 3cyclopentanedione (8). This intermediate is reduced to caldariomycin by growing
cultures of C. fumago. Based on the similarity in structure of 2,2-dichloro-1,3cyclopentanedione and 2-chloro-5,5-dimethyl-1,3-dimedone, or monochlorodimedone
(MCD), a spectrophotometric haloperoxidase assay was developed to monitor the
conversion of MCD to a dihalodimedone. The MCD assay follows the decrease in
absorbance and subsequent disappearance of MCD in the enol form at a wavelength of
290 nm (€=20 000M-1cm-1). This corresponds to the appearance of either
bromochlorodimedone or dichlorodimedone, depending on the halide reactants (Fig. 1,
44).
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Figure 1. The Monochlorodimedone Assay.

Marine algae synthesize halogenated organics with antifungal and antibacterial
activity, possibly as antifoulants. The red algae are the largest organohalogen producers
among marine algae. Red algae in the genera Bonnemaisonia and Asparagopsis, and the
green alga Penicillus capitatus produce brominated heptanones. A heme
bromoperoxidase isolated from Bonnemaisonia hamifera brominates 3-oxooctanoic acid
to form bromomethane, bromoform and 1-pentyl bromide (31). In addition, a heme
bromoperoxidase from the green alga Penicillus capitatus produces 1-bromo-2heptanone, 1,1-dibromo-2-heptanone, and 1,1,1-tribromo-2-heptanone from the
bromination of 3-oxooctanoic acid (9). B. hamifera produces 1,1,3,3-tetrabromo-2heptanone, which has antifungal activity at a concentration of 100 µg/ml and antibacterial
activity at higher concentrations (45). The crude extracts of B. hamifera inhibit nine out
of eleven bacterial strains, including several gram-positive bacteria, a Bacteriodes
bacterium, an alpha Proteobacterium, and four gamma Proteobacteria (46). However,
brominated heptanones are not inhibitory toward E. coli LE392 or Pseudomonas putida
KT2440 (46). These halogenated extracts reduce the microbial load on B. hamifera
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compared to other red algae. Many algae use organohalogens as antifouling agents. In
particular, the Australian red macroalga Delisea pulchra produces brominated furanones
that disrupt the growth of gram-negative biofilms. The brominated furanones inhibit
gram-negative bacterial lactone signaling by preventing acyl lactones from binding with
their receptors on nearby bacteria (47).
Most of the organohalogens that bacteria synthesize are antibiotics. However,
heme haloperoxidases in bacteria show diverse catalytic activity and may play a more
important role in hydrogen peroxide degradation. Bacterial heme haloperoxidases
catalyze peroxidase and catalase reactions in addition to halogenation. This is also true
of the heme chloroperoxidase from Caldariomyces fumago, which has peroxidase,
catalase, and cytochrome P450 activity (48). The first isolated bacterial heme
bromoperoxidase was from Streptomyces phaeochromogenes (32). A bromoperoxidasecatalase was later found in Streptomyces venezuelae ISP 5230. The bromoperoxidasecatalase has catalase, low peroxidase, and brominating activity (33). Both Streptomyces
strains produce the chlorinated antibiotic chloramphenicol, but haloperoxidase genes
were not found in the gene cluster coding for enzymes involved in the biosynthesis of
chloramphenicol. Similarly, several bacteria in the Pseudomonas genus synthesize the
chlorinated antibiotic pyrrolnitrin, but their heme haloperoxidases are not involved in its
production, although some can halogenate pyrrole derivatives. The bromoperoxidase
from Pseudomonas aureofaciens ATCC 15926 mutant strain ACN does not halogenate
pyrrolnitrin, but does have catalase, peroxidase and brominating activity (49). In fact, the
catalase negatively affects brominating activity by depleting available hydrogen peroxide
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in the reaction. Another pseudomonad with hydrogen peroxide degradation ability is
from the Pseudomonad EF group 70B. It was found in recycled pulp process waters
enriched with hydrogen peroxide (50). This bromoperoxidase-catalase has high catalase
activity with halogenation as a side reaction.
There are some strains of Pseudomonas that have both heme and non-heme
haloperoxidases. The bacterium Pseudomonas pyrrolnitrica has a heme containing
catalase-bromoperoxidase and four non-heme bromoperoxidase isoenzymes (51). The
non-heme haloperoxidases catalyze reactions including halogenations, oxidations,
sulfoxidations, and epoxidations (52). Another pyrrolnitrin producer, Pseudomonas
pyrrocina ATCC 15958, has a heme bromoperoxidase (53) and a non-heme
chloroperoxidase (54). However, neither the heme nor the non-heme haloperoxidase is
responsible for the halogenation of pyrrolnitrin (55, 13). The heme-haloperoxidases in
the Streptomyces and Pseudomonas do not produce the chlorinated antibiotics
chloramphenicol or pyrrolnitrin (11, 13, 55).

Vanadium Haloperoxidases
The vanadium haloperoxidases are different from the heme haloperoxidases in
that they require the transition metal vanadium and halides for the breakdown of
hydrogen peroxide. In the heme haloperoxidase reaction, the heme cofactor is oxidized
from the degradation of hydrogen peroxide (56), but in the vanadium haloperoxidase
reaction the vanadium oxidation state does not change (57). However, vanadium
haloperoxidases are inhibited by high concentrations of hydrogen peroxide (58). The
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most important difference between the heme and vanadium haloperoxidases is that some
vanadium haloperoxidases can bind particular organic substrates and halogenate them in
a regiospecific manner.
Most vanadium haloperoxidases are bromoperoxidases from marine algae, but
some are also found in terrestrial fungi and marine bacteria. Vanadium
bromoperoxidases are prominent in marine environments, where vanadium is the second
most abundant transition metal (59), and bromide is present in high concentrations (1).
Marine algae are promising sources of natural products because they manufacture heme
and vanadium haloperoxidases and a wealth of halogenated metabolites. In the terrestrial
environment, vanadium chloroperoxidases can be found in the fungi Curvularia
inaequalis and Embellisia didymospora (60, 61). C. inaequalis is a pathogen of Zea
mayes and may use vanadium chloroperoxidases to produce hypohalous acids and
hydroxyl radicals that damage plant cell walls (62). These are the only peroxidases
secreted by C. inaequalis. Representative vanadium haloperoxidase reactions from
different organisms are outlined in Table 2.
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Table 2. Vanadium Haloperoxidase Reactions.
Enzyme & Species
Algae
Phaeophyceae
(Brown algae)
Bromoperoxidase
Fucus distichus,
Macrocystis pyrifera
Bromoperoxidase
Ascophyllum nodosum

Substrate

Organohalogens

cytosine
taurine, Tris, Capso,
Tes, Hepes, Mops

5-bromocytosine
Br-taurine, Br-Tris, Br-Capso,
Br-Tes, Br-Hepes, Br-Mops (63)

2-methylindole
2-phenylindole
phenol red
(E)-(+)-nerolidol

3-bromo-2-methylindole
3-bromo-2-phenylindole
bromophenol blue (64)
α-snyderol, β-snyderol, γsnyderol
(+)-3β-bromo-8-epicaparrapi
oxide (65)

Rhodophyceae
(Red algae)
Bromoperoxidase
Corallina officinalis,
Plocamium
cartilagineum,
Laurencia pacifica
nerol
Bromoperoxidase
Corallina officinalis,
Plocamium
cartilagineum,
Laurencia pacifica
Fungi

3-bromo-2,2,6-trimethyl-3,4,5,8tetrahydro2H-oxocine (66)

Chloroperoxidase
hydrogen peroxide
hypochlorous acid (62)
Curvularia inaequalis,
Embellisia
didymospora
Bacteria
Chloroperoxidase
napyradiomycin (67)
1,3,6,8Streptomyces
tetrahydroxynaphthalene
aculeolatus NRRL
18422
Streptomyces sp.
CNQ-525
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The first vanadium haloperoxidase discovered was a vanadium bromoperoxidase
from the brown marine alga, Ascophyllum nodosum. Competitive kinetic experiments
and fluorescence quenching results show that the vanadium bromoperoxidase preferably
brominates bound indole substrates (64). If indole is not bound, hypobromous acid can
diffuse from the active site to halogenate unbound substrates. In addition to
hypobromous acid, other oxidized vanadium bromoperoxidase intermediates are bromine,
tribromide, and an enzyme bound “bromonium ion equivalent” (63). All these
intermediates can act as halogenating agents. The vanadium bromoperoxidase from A.
nodosum is one of the first characterized haloperoxidases that binds 2-methylindole and
2-phenylindole substrates, and halogenates them specifically to 3-bromo-2-methylindole
and 3-bromo-2-phenylindole (Table 2, 64). Another brown alga, Laminaria digitata has
both a vanadium bromoperoxidase and iodoperoxidase, and is one of the greatest iodine
bioaccumulators of all living organisms (68). The bromoperoxidase catalyzes the
bromination of monochlorodimedone and the iodoperoxidase converts iodide to triiodide.
The iodine content in L. digitata is 1% of its dry weight, which is approximately a
30,000-fold accrual of iodine from seawater (69). The storage of iodine may aid in
ultraviolet protection and as an antifouling agent. Haloperoxidases from L. digitata can
also generate hypobromous acids that deactivate 3-oxo-acyl homoserine lactones
involved in Pseudomonas aeruginosa biofilm formation and dispersal (70). The
hypohalous acids and halogenated products from algae have antibacterial and antifouling
abilities.
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The red marine algae Corallina officinalis, Plocamium cartilagineum, and
Laurencia pacifica produce chiral brominated sesquiterpenes that act as precursors to
natural products. These algae use vanadium bromoperoxidases to catalyze the
enantiospecific bromination of sesquiterpenes through bromonium-ion induced
cyclization (65, 66). The nerolidol and vanadium bromoperoxidase reaction synthesizes
single diastereomers of β-snyderol and γ-snyderol (Table 2). The compounds α-snyderol,
β-snyderol, and laurencin are naturally produced by select red algae. Laurencin is very
similar in structure to the monobromocyclic ether synthesized from the reaction of nerol
and vanadium bromoperoxidase (66, Table 2). The vanadium haloperoxidases in these
red algae synthesize brominated sesquiterpenes with anti-plasmoidal and cytotoxic
activity.
In bacteria, vanadium haloperoxidases may catalyze the synthesis of halogenated
antibiotics. The napyradiomycin gene cluster from Streptomyces sp. CNQ-525 was
heterologously expressed in Streptomyces albus and seven napyradiomycins were
produced (67). Napyradiomycins are dihydroquinone antibiotics. Analyses of genes in
the napyradiomycin pathway show three putative vanadium chloroperoxidase genes in
Streptomyces aculeolatus NRRL 18422 and the marine bacterium Streptomyces sp. CNQ525 (67). The vanadium chloroperoxidases produced from these genes may cause the
chloronium-induced cyclization of two terpene units in the meroterpenoid
napyradiomycin biosynthetic pathway. Bromonium and chloronium-induced cyclization
seems to be a common mechanism for the production of enantiospecific halogenated
compounds among vanadium haloperoxidases in marine algae and bacteria. A vanadium

15

bromoperoxidase gene was found in the cyanobacterium Synechococcus CC9311 (71).
This is the first documentation of a bromoperoxidase gene and activity in free-living
unicellular cyanobacteria (72). The vanadium bromoperoxidase sequenced from
Synechococcus CC9311 is similar to vanadium bromoperoxidases in red algae and
homologous to bromoperoxidases in the marine bacteria Acaryochloris marina,
Synechococcus sp. PCC7335, and Crocosphaera watsonii. The vanadium
bromoperoxidase gene appears to be within a cluster of horizontally transferred genes
that may be from red algae (72). A. marina is a common epiphyte of red algae that may
have acquired the bromoperoxidase from red algae, and transferred it to other
photoautotrophic bacteria. The vanadium bromoperoxidase halogenates
monochlorodimedone, but is not thought to have a specific organic substrate. Although
brominated compounds have not been isolated from this bacterium, cyanobacteria do
produce halogenated metabolites. Oscillatoria spongeliae lives as an endosmybiont in
the marine sponge Dysidea herbacea and produces polybrominated biphenyl ethers (73).
Genome mining research may find more vanadium haloperoxidases and halogenated
products present in marine bacteria.

Cofactor-Free Haloperoxidases (Perhydrolases)
The cofactor-free haloperoxidases are perhydrolase enzymes that use organic
acids such as acetate, propionate, or benzoate for halogenation. These enzymes do not
break down hydrogen peroxide and thus are not true peroxidases. The perhydrolases
have the same catalytic triad as serine hydrolases (Ser-Asp-His) and belong to the large
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and diverse alpha/beta (α/β) hydrolase fold enzyme class (74). The nucleophilic serine is
typically found in the consensus sequence Gly-X-Ser-X-Gly (75). Perhydrolases catalyze
halogenation reactions through the reversible formation of peracids (22). The peracids
oxidize halides, which then halogenate organic substrates unspecifically.
The perhydrolase reaction mechanism is based on the serine residue of the active
site attacking the carboxyl carbon of an organic acid and forming an acyl-enzyme. In the
case of acetic acid, this bond is subsequently hydrolyzed by hydrogen peroxide to
generate peracetic acid (76). The peracetic acid reacts with halides transported to the
active site, forming hypohalous acids and other intermediates. The hydrophobic
environment of the active site seems to protect the peracid against hydrolysis (76). There
does not appear to be a binding site on the enzyme for halides, hypohalous acids, or
specific substrates. These perhydrolases are not responsible for the synthesis of natural
halogenated products, but do halogenate monochlorodimedone and other suitable
substrates (Table 3).

Table 3. Halogenation Reactions of Cofactor-Free Haloperoxidases.
Enzyme & Species
Bacteria
Chloroperoxidase
Streptomyces lividans
TK64
Chloroperoxidase
Pseudomonas
pyrrocinia
ATCC 15958

Substrate

Organohalogens

indole

Monochloroindole (77)

indole
4-(2-amino-3chlorophenyl) pyrrole

7-chloroindole (54)
Aminopyrrolnitrin (78)
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The cofactor-free haloperoxidases are primarily found in bacteria, mainly from
the genera Pseudomonas and Streptomyces (51, 54, 77-79). However, the nocardioform
actinomycete, Rhodococcus erythropolis induces a non-heme haloperoxidase during the
biodegradation of thiocarbamate herbicides (80). The enteric bacterium Serratia
marcescens also synthesizes a non-heme chloroperoxidase that hydrolyzes carboxylic
acids, oxidizes amines to nitro compounds, and has phosphatase activity (81, 82). The
catalytic triad of perhydrolases is essential to the diversity of reactions that these enzymes
can perform. It acts on various substrates in different biological contexts and can
hydrolyze carboxylic acid esters, lipids, thioesters, peptides, epoxides, haloperoxides, and
dehalogenases (75, 83). Although the perhydrolases are not true haloperoxidases, they
can perform halogenation reactions if an appropriate organic acid is present.

FADH2-Dependent Halogenases
As the name implies, the FADH2-dependent halogenases require a reductase to
generate FADH2 from FAD and NADH or NADPH. The flavin co-substrate binds to a
specific nucleotide site near the amino terminal (GxGxxG) of the enzyme (84). Some
halogenases have a second conserved motif near the middle of the enzyme for two
tryptophan residues (WxWxIP). These conserved residues reflect the enzyme’s substrate
specificity for tryptophan and indole derivatives. The halogenation of tryptophan at the
C7 position is the first reaction in the biosynthesis of the antibiotic pyrrolnitrin and the
antitumor compound rebeccamycin (12, 85, Table 4). Other halogenases preferentially
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bind phenol and pyrrole derivatives. Several tryptophan halogenase reactions are
illustrated in Table 4.
Table 4. Representative FADH2-Dependent Halogenase Reactions.
Enzyme & Species
Substrate
Protista
Flavin-dependent halogenase 2,4,6-trihydroxyphenyl(chlA)
1-hexa-1-one (THPH)
Dictyostelium discoideum
Bacteria
Tryptophan 7-halogenase
tryptophan
(prnA)
Pseudomonas fluorescens
BL915
Monodechloraminopyrrolnitrin monodechloroaminohalogenase
pyrrolnitrin
(prnC)
Pseudomonas fluorescens
BL915
Tryptophan 7-halogenase
tryptophan
(rebH)
Lechevalieria aerocolonigenes
str. 39243
Tryptophan 5-halogenase
tryptophan
(pyrH)
Streptomyces rugosporus LL42D005
Tryptophan 6-halogenase
tryptophan
(thal)
Streptomyces albogriseolus
MJ286-76F7

Organohalogens
dichloro-THPH (86)

7-chlorotryptophan
(12)

aminopyrrolnitrin
(13)

7-chlorotryptophan
(85)

5-chlorotryptophan
(17)

6-chlorotryptophan
6-bromotryptophan
(19)

Although the regioselective halogenation mechanism of FADH2-dependent
halogenases is not fully understood, the dependence on oxygen in the reaction may result
in the formation of flavin hydroperoxide. The hydroperoxide could activate aromatic
rings by forming an epoxide, which when attacked by halide ions can generate
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regiospecific compounds, such as halohydrins (12). The flavin hydroperoxide could also
form reactive FAD-O-Cl or hypohalous acid intermediates that halogenate substrates in a
specific manner within the active site (20-21, 85). Regardless of the exact mechanism,
the FADH2-dependent halogenases produce many halogenated antibiotics and a
chlorinated differentiation factor (Table 4). Until 1997, haloperoxidase enzymes were
thought to be the main halogenating enzymes, but FADH2-dependent halogenases
synthesize many more halogenated antibiotics in bacteria than other halogenation
enzymes (84, 87).
The FADH2-dependent halogenases produce several halogenated antibiotics and a
growth hormone and are predicted to generate halogenated antifungal and antitumor
compounds. These enzymes generate the halogenated antibiotics 7-chlorotetracycline,
chloramphenicol, pyrrolnitrin, pyoluteorin, balhimycin, pyrroindomycin B, thienodolin,
and clorobiocin (10-19). Though haloperoxidases are found in bacteria that produce the
antibiotics pyrrolnitrin and chloramphenicol, they do not catalyze halogenation of these
compounds (55, 13). The prnA and prnC genes in the pyrrolnitrin biosynthetic gene
cluster of Pseudomonas fluorescens show similarity to FADH2-dependent halogenases
and not haloperoxidases. Furthermore, FADH2-dependent halogenases encoded by the
gene cmlS and adenylation enzymes encoded by the gene cmlK are responsible for the
biosynthesis of the dichloroacetyl component of chloramphenicol in Streptomyces
venezuelae ISP5230 (11). Therefore, it is evident that FADH2-dependent halogenases
instead of haloperoxidases are responsible for the synthesis of halogenated antibiotics in
these bacteria.
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Two FADH2-dependent halogenase genes are also found in the antifungal and
antimicrobial kutznerides gene cluster isolated from soil actinomycetes (88).
Kutznerides are cyclic depsipeptides consisting of six nonproteinogenic residues,
including a chlorinated piperazic acid (88). One FADH2-dependent halogenase appears
to be involved in the formation of 6,7-dichlorohexahydropyrroloindole and another in the
chlorination of the piperazate unit. The gene cluster was constructed from degenerate
primer-based PCR amplification of highly conserved mononuclear non-heme iron and
FADH2-dependent halogenase genes in Kutzneria sp. 744. This gene cluster encodes six
nonribosomal peptide synthetase (NRPS) modules, which are often responsible for the
production of important pharmaceuticals. In NRPS modules, there are usually three
functional domains consisting of an adenylation domain, a peptidyl carrier protein
domain, and a condensation domain (89).
A FADH2-dependent halogenase in the amoeba Dictyostelium discoideum
produces a halogenated compound for differentiated expression. This chlorinated
differentiation-inducing factor (DIF-1) transforms amoeba cells into stalk cells by
activating the expression of prestalk genes (3, 90). From enzymatic activity in vitro,
researchers deduced that a heme chloroperoxidase twice chlorinates the polyketide
precursor 2,4,6-trihydroxyphenyl-1-hexa-1-one (THPH) to form dichloro-THPH.
Subsequently, the dichloro-THPH is methylated to form DIF-1 (90). The chlorination of
THPH was based on chloroperoxidase activity and not supported with genetic evidence.
Recently, the chlorinating gene was found to be chlA, a FADH2-dependent halogenase.
RT-PCR analysis reveals that the halogenase is up-regulated along with genes encoding a
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polyketide synthase stlB and methylation enzyme dmtA (86). The polyketide synthase is
involved in THPH formation. The halogenase was overexpressed in D. discoideum and
upon reaction with THPH, the halogenase formed Cl-THPH, which was confirmed with
liquid chromatography-mass spectrometry (86). In vivo experiments show that FADH2dependent halogenase knockout mutants of D. discoideum had a deficiency in DIF-1,
which led to collapsed fruiting bodies. This is the first example of a FADH2-dependent
halogenase in a eukaryote combined with an organohalogen acting as a transcriptional
activator. Other organisms may use organohalogens as growth hormones.
FADH2-dependent halogenases are proposed to synthesize the halogenated
antitumor compounds rebeccamycin and neocarzilin in bacteria. Rebeccamyin has two
chlorinated indole rings and is an indolocarbazole antitumor agent that functions as a
weak topoisomerase I inhibitor (85). Two genes in the rebeccamycin gene cluster are
predicted to code for a flavin reductase (rebF) and FADH2-dependent halogenase (rebH).
These genes from L. aerocolonigenes were overexpressed in E.coli and produced
reductase and halogenases that halogenate tryptophan in the first reaction of
rebecaamycin synthesis. The neocarzilin antitumor compounds are aliphatic
halometabolites characterized by their chloromethyl groups (91). The bacterium
Streptomyces carzinostaticus var. F-41 has 14 open reading frames (ORFs) involved in
the synthesis of neocarzilin. The chlorination step is likely from the product of ORF3,
which encodes a FADH2-dependent halogenase, while ORF8 codes for a flavin reductase
gene. The FADH2-dependent halogenases are involved in the production of many
antimicrobial products and some antitumor compounds in bacteria.
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Summary
Many organisms produce haloperoxidases and FADH2-dependent halogenases
that are involved in the formation of organohalogens. The hypohalous acids produced in
these reactions act as halogenating agents when appropriate organic substrates are
present. Hypohalous acids are also used as biocidal agents. The vanadium
bromoperoxidases of marine algae synthesize brominated organics with antibacterial,
antifouling, and cytotoxic activity (9, 45-47, 65-66). But it is the FADH2-dependent
halogenases that are the primary producers of halogenated antibiotics and antitumor
compounds in bacteria (Table 4). Recently, however, vanadium chloroperoxidases and
bromoperoxidases were found in two bacterial strains (67, 72). In fact, Pseudomonas and
Streptomyces produce heme and non-heme haloperoxidases, vanadium haloperoxidases,
and FADH2-dependent halogenases. More bacteria should be screened for halogenation
enzymes. These enzymes are beneficial in green-chemical processes, and new
pharmaceutical compounds may be discovered.

Specific Goals of This Study
Marine acorn worms are shell-less organisms that produce halogenated organics,
mainly bromophenols. Organohalogens are common chemical defenses found in species
that do not have a hard outer shell or other physical protection against predators. Acorn
worms may bioaccumulate microorganisms in the sand for the production of
organohalogens. Symbiotic bacteria living with marine acorn worms may produce
halogenation enzymes that have the capacity to brominate phenolic compounds. To test
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this idea, bacteria were isolated from the slime associated with the red-banded acorn
worm Ptychodera jamaicensis. The goal of this research was to characterize the marine
bacteria present on the red-banded acorn worm Ptychodera jamaicensis and screen for
halogenation genes and enzyme activity. This research will help to increase our
understanding of acorn worm organohalogen production. The following genes and
enzymes were assayed:
1. the 16S rDNA gene in each bacterial isolate to characterize the bacteria present
on the worm,
2. bromoperoxidase and FADH2-dependent halogenase genes,
3. bromoperoxidase enzyme activity in partially purified protein fractions.
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Introduction
Organohalogens have numerous impacts on organisms and the environment.
Many organohalogens such as DDT and CFCs are man-made environmental pollutants,
but there are more than 3,800 organohalogens produced naturally in the environment (1).
These compounds persist in the environment due to the lipid solubility of their halogen
subunit, which also decreases their water solubility (2). Organohalogens are relatively
stable chemicals. Many organisms bioaccumulate halogenated compounds as defensive
chemicals, which also have antibiotic and/or anti-cancer properties. Halogenated
compounds are useful as pharmaceuticals because they can penetrate lipid membranes to
reach their cellular target. It is important to identify strains of bacteria that have
halogenation enzymes to better understand the context in which they are produced and to
discover new biopharmaceuticals and enzymatic pathways. Halogenation enzymes can
also be used in environmentally sustainable chemical reactions.
The main halogenation enzymes are the haloperoxidases and FADH2-dependent
halogenases. These halogenation enzymes are attractive alternatives for use in chemical
halogenation processes because haloperoxidases oxidize halogens with hydrogen
peroxide and the FADH2-dependent halogenases use oxygen. Water is the side product
formed. These enzymes would decrease the need for toxic molecular halogens and
petroleum-based chlorinated solvents in the production of halogenated organics (3). The
perhydolases or cofactor-free haloperoxidases from bacteria can be enzymatically
coupled with enzymes, such as glucose oxidase to enhance the efficiency of bleaching
processes in the textile and paper industries. More than 60% of the world’s production of
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hydrogen peroxide is consumed in these processes (3). Glucose oxidase is an enzyme
that generates hydrogen peroxide, which is used by perhydrolases to form peracids (4).
Modified enzymes can reduce the use of hydrogen peroxide, peracids, and chlorinated
waste products in bleaching processes. Biomimetic research focuses on how these
enzymes are used naturally to produce organohalogens. This knowledge can be used to
develop bioengineered enzymes and products.
One source of these enzymes is marine acorn worms, which produce many
organohalogens including bromophenols, bromopyrroles, bromo- and chloroindoles,
bromohydroquinones, and bromo-cyclohexanes (5, 6). These compounds may act as
chemical deterrents to encroaching organisms. Bacteria present on or in these worms
may synthesize halogenation enzymes that are involved in the production of these
compounds. In Streptomyces, vanadium chloroperoxidases produce the chlorinated
antibiotic napyradiomycin. In general, FADH2-dependent halogenases produce most of
the halogenated antibiotics in bacteria (7, 8-17). This study investigates if bacteria
associated with the red-banded acorn worm Ptychodera jamaicensis have halogenation
genes and the capacity to synthesize halogenated compounds.
Forty-eight bacterial strains were isolated from the slime associated with the
acorn worm and a phylogenetic tree was constructed based on the 16S rDNA gene of
each isolate. Genomic DNA was screened for bromoperoxidase and FADH2-dependent
halogenase genes to ascertain if the bacteria are capable of synthesizing these enzymes
and possibly organohalogens. Bromoperoxidase primers were designed from the
bromoperoxidase consensus sequence of five Bacillus strains, and FADH2-dependent
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halogenase primers were ordered based on the work of Hornung et al. (18). To test the
isolates for bromoperoxidase activity, the enzymes were partially purified from crude
protein extracts with ammonium sulfate precipitation and anion exchange
chromatography. Activity was measured with a phenol red and monochlorodimedone
assay.
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Experimental Procedures
16S rDNA Amplification, Sequencing and Phylogenetic Analysis-The genomic
DNA of 48 bacterial isolates from the slime of the red-banded acorn worm, Ptychodera
jamaicensis was extracted using a Midi-Prep Kit for Isolation of Genomic DNA for
bacteria (Qiagen, Valencia, CA). The bacterial 16S rDNA gene was amplified using the
16S ribosomal DNA universal bacterial Fd1 and Rd1 primers (19). Primers were
synthesized by Operon Biotechnologies, Inc. (Huntsville, AL). A 40 µl PCR reaction
contained: 8 µl 5X PCR Buffer, 4 µl Fd1 and Rd1 primers (10µM) each, 8 µl dNTPs
(1mM), 4 µl MgCl2 (25mM), 0.6 µl Taq Polymerase (5u/µl), 7.4 µl H2O, and 4 µl
genomic DNA (.3 ng). The PCR was performed in a MJ Research PTC-100® Peltier
Thermal Cycler (Global Medical Instrumentation, Inc., Ramsey, MN) under the
following cycling conditions: 1) denaturation for 2 min at 95oC, followed by 2) 34 cycles
of denaturation for 15 sec at 95oC, annealing of primers for 30 sec at 55oC, extension of
primers for 2 min at 72oC, and 3) a final extension for 6 min at 72oC. The presence of the
16S rDNA gene was confirmed with gel electrophoresis using 1.5% agarose gels. The
gels were stained with ethidium bromide and visualized with ultraviolet light in a GelDoc
TM

XT 170-8171 (BioRad Laboratories, Hercules, CA).
The isolates that showed a positive result for the 1.5-kilobase 16S rDNA gene

were purified using a QIAquick® PCR purification kit (Qiagen, Valencia, CA). After
purification, they were sent for sequencing to Sequetech Corporation (Mountain View,
CA). The returned sequences were analyzed and edited with 4peaks software
(http://www.mekentosj.com/science/4peaks). A basic local alignment search tool
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(BLAST) search was performed using nucleotide blast
(http://blast.ncbi.nlm.nih.gov/Blast.cgi, 20). The closest similarity matches for each 16S
rDNA sequence were aligned using ClustalW2-Multiple Sequence Alignment
(http://www.ebi.ac.uk/Tools/msa/clustalw2/, 21, 22). The aligned nucleotide sequences
were saved in Fasta format and converted to a molecular evolutionary genetics analysis
(MEGA) file to build a neighbor-joining phylogenetic tree with MEGA software (23).
The out-group was the cyanobacterium Nostoc sp. PCC 7120, and Bacillus cereus and
Escherichia coli were included as reference type strains.
The 16S rDNA PCR products that did not yield a sequence were cloned into
pGEM-T Easy plasmid vectors (Promega, Madison, WI) according to manufacturer’s
instructions. The plasmids were used to transform competent E. coli JM109 cells
(Promega, Madison, WI) or competent E. coli DH5α cells prepared with a calcium
chloride protocol. The plasmids were purified using a Wizard Plus SV Miniprep Kit
(Promega, Madison, WI) and screened by restriction analysis using EcoR1 (12u/µl). The
plasmids with the 1.5kb 16S rDNA gene were sent to Sequetech Corporation (Mountain
View, CA) for unidirectional sequencing of 1,000 nucleotides with the forward primer
M13F.

Bromoperoxidase Amplification, Sequencing, and Phylogenetic AnalysisBromoperoxidase primers were designed based on the aligned sequences of five bacterial
bromoperoxidases from the genus Bacillus. Bacillus anthracis str. “Ames Ancestor”,
Bacillus cereus AH820, Bacillus cereus ATCC 10987, Bacillus cereus B4264, and
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Bacillus cereus G9842 were the five species used for selecting the bromoperoxidase
consensus sequence. The forward and reverse primer sequences are: Fd-BPO 5’-CCC
ATG TGG ACC ACC CTT TAT-3’ and Rv-BPO 5’-TAA GTG GTC GAT CTT GGG
AAT-3’. These primers were used to screen genomic DNA samples of bacteria
associated with the red-banded acorn worm. The PCR reaction and cycling conditions
were the same used for the 16S rDNA gene amplification, but with the bromoperoxidase
primers.
The bromoperoxidase primers amplified a 700-base-pair (bp) fragment that was
visualized with gel electrophoresis using 1.5% agarose gels. Each 700-bp
bromoperoxidase gene fragment obtained was purified using the QIAquick® PCR
purification kit (Qiagen, Valencia, CA) and sent to Sequetech Corp. (Mountain View,
CA) for sequencing. The identity of the sequences was confirmed with a BLAST search
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The genomic DNA from Bacillus cereus was
used as the positive control, and a sterile water sample was the negative control. The
genomic DNA from the gram-negative bacterium Escherichia coli and the archaeon
Methanosarcina mezai were also screened for the bromoperoxidase gene fragment. This
was to test if the primers are specific for bromoperoxidases from the Bacillus genus. The
primers may have a broad range and amplify bromoperoxidase genes in other bacterial
genera.
Bromoperoxidase sequences from the bacteria Bacillus cereus G9842,
Nocardiopsis dassonvillei subsp. dassonvillei DSM 43111, and Streptomyces sp. Mg1
were aligned with the bromoperoxidase from isolate I37 using ClustalW2

39

(http://www.ebi.ac.uk/Tools/msa/clustalw2/). The Clustal alignment was done to
visualize similarity between the bromoperoxidase from isolate I37 with
bromoperoxidases from other genera. A neighbor-joining bromoperoxidase phylogenetic
tree was constructed using MEGA to compare the relatedness of the bromoperoxidase
from isolate I37 with bromoperoxidases from red algae, brown algae, and other bacteria
(23). The aligned bromoperoxidase sequences were from the red algal Corallina
officinalis, the brown algal Laminaria digitata, and the bacteria Bacillus cereus G9842,
Bacillus anthracis, Nocardiopsis dassonvillei susbp. dassonvillei DSM 43111,
Streptomyces sp. Mg1, and Synechococcus sp. CC9311.

Bromoperoxidase Purification: Sonication, Ammonium Sulfate Precipitation, and
Anion-Exchange Chromatography-Eight isolates positive for the bromoperoxidase gene
fragment were grown to an optical density (OD) between 0.6-0.8 at 600 nm in 1.5 L of
nutrient broth (7.5 g tryptone-peptone, 3.75 g beef extract) supplemented with 0.10 g KBr
and 9.38 g NaCl. The cells were collected using a Sorval RC2-B centrifuge at 4oC, 5,000
rpm for 10 min. They were washed twice with 5 ml phosphate buffered saline (0.1 M
PBS, pH 7) and pelleted at 4oC, 14,000 rpm for 10 min. Each wash included
resuspension and pelleting. The cells were resuspended in 5-10 ml of 50 mM Tris-HCl,
pH 7.4, and sonicated with a Branson sonic power Sonifier cell disruptor 350 (Branson
Ultrasonics Corp., Danbury, CT). They were sonicated using a microtip for six cycles of
30 sec with a 90 sec cooling period at 160W, 50% duty cycle. The sonicated cells were
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centrifuged at 4oC, 14,000 rpm for 1 h and the supernatant kept at -20oC for no more than
48 h.
The crude protein extracts were concentrated using ammonium sulfate
precipitation. Ammonium sulfate was added to the crude protein extracts at 60%
saturation and the solutions were stirred in a cold room maintained at 4oC or below for 30
min. After this time interval, the protein mixture was centrifuged at 4oC, 15,000 rpm for
10 min. The supernatant from the 60% ammonium sulfate protein pellet was discarded
and the pellet kept at 4oC for 48-72 h before further purification with anion-exchange
chromatography.
A 1 ml HiTrap Q XL column was used for anion exchange chromatography (GE
Healthcare, Piscataway, NJ). The column was first washed with 5 ml of 20 mM TrisHCl, pH 8, at a flow rate of 1 ml/min to remove preservatives. Then 5 ml of 20 mM TrisHCl containing 1.0 M NaCl was used to equilibrate the column. Before the protein
sample was added, the column was equilibrated again with 5 ml of the start buffer (20
mM Tris-HCl, pH 8). The 60% ammonium sulfate protein pellet was resuspended in 5
ml of 20 mM Tris-HCl, pH 8, and loaded onto the chromatography column. Proteins
were eluted from the column with 5 ml samples of start buffer (20 mM Tris-HCl, pH 8)
containing increasing amounts of sodium chloride. The sodium chloride step gradient
consisted of 5 ml of 0.15 M NaCl, 0.25 M NaCl, 0.35 M NaCl, and 0.45 M NaCl
dissolved in the start buffer, 20 mM Tris-HCl, pH 8. Each step consisted of 5 ml, and the
collected fractions were 5 ml. The 5 ml eluents from the column were concentrated using
10,000 molecular weight Amicon Centricon centrifugal filter devices (Billerica, MA)
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according to manufacturer’s instruction. The concentrated protein fractions with
molecular weights greater than 10 kDa were applied to native polyacrylamide gels for
electrophoresis.

PhastSystem Separation of Proteins and Coomassie Staining-Proteins were
separated with native polyacrylamide gel electrophoresis (PAGE) using the
PhastSystem (Amersham Biosciences, Piscataway, NJ). Two µl samples from the
concentrated protein samples, the positive and negative controls, and a high-molecular
weight (HMW) ladder were loaded onto 8-25% gradient polyacrylamide gels (Amersham
Biosciences, Piscataway, NJ). The positive control for bromoperoxidase activity was the
bromoperoxidase from the red alga Corallina officinalis (Sigma Aldrich, St. Louis, MO).
The negative control was boiled bovine serum albumin (Promega Corp., Madison, WI).
After protein separation and the phenol red gel assay, the gels were transferred to the
PhastSystemTM (Amersham Biosciences Corp., Piscataway, NJ) for CoomassieTM
staining with PhastGel BlueR (Amersham Biosciences Corp., Piscataway, NJ). The
HMW protein ladder was used to determine approximate protein weights.

Phenol Red Gel Assay-After protein separation, the gels were placed in 10 ml of a
phenol red assay solution and 100 µl of 1% H2O2 was added to begin the reaction. The
phenol red assay solution consisted of: 1 M sodium acetate buffer, 1 M sodium bromide,
and 0.002% phenol red at a pH of 5.5. The gels were observed for 30 min for
bromoperoxidase activity. After twenty min, approximately 100 µl of 1% hydrogen
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peroxide was added again to ensure other enzymes did not deplete the hydrogen peroxide.
The phenol red substrate undergoes a color change from yellow to blue when phenol red
is brominated, as shown in Figure 2. The appearance of blue protein bands in the
polyacrylamide gels was the result of the formation of bromophenol blue and indicated a
positive protein sample with bromoperoxidase activity.

Figure 2. The Phenol Red Assay.

Monochlorodimedone Assay-The protein fractions positive for bromoperoxidase
activity in the phenol red gel assay were tested in the monochlorodimedone (MCD)
assay. This continuous spectrophotometric assay monitors the decrease in absorbance of
MCD at a wavelength of 290 nm (Fig. 1). It is carried out at 25oC in 0.1 M sodium
acetate buffer, 0.1 M potassium bromide, and 50 µM MCD at a pH of 5.5. This buffer (1
ml) was added to a quartz cuvette along with 20 µl of the bromoperoxidase active protein
sample. Hydrogen peroxide at a concentration of 8.8 mM was added to begin the
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bromoperoxidase reaction. If bromoperoxidase activity was not detected after 20 min,
100 µl of 1% hydrogen peroxide was added to ensure enough substrate in the reaction.
The conversion of 1 µmol of MCD in 1 min is defined as one unit (U) of enzyme activity
(24). The MCD substrate can be chlorinated or brominated depending on the
haloperoxidase and halides present. Eventually all the MCD is consumed and the OD
reaches zero, indicating reaction termination.

Bacterial Growth Curve of Isolate I37-A 3 L nutrient broth culture of isolate I37
was grown in a 6 L round bottom flask. The culture was maintained between 23oC and
25oC with shaking at 150-250 rpm for 48 h. The OD at 600 nm was taken every hour to
generate a bacterial growth curve.

FADH2-Dependent Halogenase Amplification, Sequencing and Phylogenetic
Analysis-The genomic DNA of the isolates was screened with the degenerate FADH2dependent halogenase primers, Halo-B4-FW 5’-TTC CCS CGS TAC CAS ATC GGS
GAG-3’ and Halo-B7-RV 5’-GSG GGA TSW MCC AGW ACC ASC C-3’ (18). The
primers allow for wobble between bases. The base “S” can code for either a cytosine or
thymine, a “W” codes for a guanine or cytosine, and an “M” codes for either adenine or
cytosine. The 50 µl PCR reaction contained: 10 µl 5X PCR buffer, 3 µl Halo-B4-FW
and Halo-B7-RV primers (10 µM each), 2 µl dNTPs (10 mM), 5 µl MgCl2 (25 mM), 0.5
µl Taq Polymerase (5u/µl), 22.5 µl H2O, and 4 µl genomic DNA (0.2 ug). The PCR was
performed under the following cycling conditions: 1) denaturation for 3 min at 94oC,
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followed by 2) 30 cycles of denaturation for 1 min at 94oC, annealing of primers for 1.5
min at 58oC, extension of primers for 1 min at 72oC, and 3) a final extension for 5 min at
72oC.
Isolates that had a 1,000-bp gene fragment in the 1.5% agarose gel were purified
with the QIAquick® PCR purification kit (Qiagen, Valencia, CA) and sent for sequencing
to Sequetech Corp. (Mountain View, CA). The returned 1,000-bp halogenase sequence
from isolate X36 was analyzed with a BLAST search
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and aligned with tryptophan halogenases from
Paenibacillus sp. JDR-2 and Bacillus cereus subsp. cytotoxis NVH 391-98 using
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/). A neighbor-joining
phylogenetic tree was constructed using MEGA software to compare various halogenases
from different genera of bacteria (23). The phylogenetic tree consisted of the halogenase
from isolate X36 and halogenases from Micromonospora sp., Salinospora arenicola,
Paenibacillus sp. JDR-2, Streptosporangium nondiastaticum, Pseudomonas fluorescens
Pf-5, Catenulispora acidiphila, Streptomyces griseoflavus, Streptomyces albogriseolus,
Nocardia beijingensis, and Bacillus cereus subsp. cytotoxis.
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Results
16S rDNA Phylogenetic Tree-The 48 bacterial isolates obtained from the acorn
worm are represented in the phylogenetic tree in Figure 3. Each isolate is designated
alphanumerically and with a species name. The species name represents the closest
BLAST similarity match for each 16S rDNA gene. The 16S rDNA gene for all of the
isolates had a 97% or greater similarity to the species shown in Figure 3, except for
isolates M16 and LL16. These isolates have similarities of 96% and 93%, respectively.
Phylogenetic analyses reveal that the bacteria isolated from the red-banded acorn
worm Ptychodera jamaicensis belong to the Firmicutes and Actinobacteria phyla (Fig. 3).
Thirty-six of the 48 bacterial isolates belong to Firmicutes. They are designated with a
pink ellipsis (Fig. 3). Thirty-five of these bacteria are in the family Bacillaceae and one
in the Paenibacillaceae. The 36 Firmicutes belong to the genera Bacillus, Halobacillus,
Paenibacillus, and Paucisalibacillus. The remaining 12 bacterial isolates are
Actinobacteria. Four of these Actinobacteria are in the Micrococcaceae, two from the
Microbacteriaceae and Nocardiaceae, and one from the Nocardiopsaceae. The genera of
these Actinobacteria include Rhodococcus, Kocuria, Arthrobacter, Streptomyces,
Micrococcus, Curtobacterium, Microbacterium, and Janibacter.
The 16S rDNA phylogenetic tree was constructed using the neighbor-joining
method, and bootstrap values are shown at the tree nodes. The bootstrap values are
percentages in which the taxa associated cluster together out of 500 replicate trees (25).
The bootstrap values are lowest between isolates in the Firmicutes I and Firmicutes II but
higher between the Actinobacteria I and II. The highest bootstrap value of 100 occurs
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where the Firmicutes I and Actinobacteria I branch from the Firmicutes II and
Actinobacteria II. The Firmicutes I and Actinobacteria I are separated from the
Firmicutes II and Actinobacteria II by isolate LL16 (Fig. 3). LL16 is 93% similar to a
Bacillus sp., but is not clustered with either the Firmicutes I or Firmicutes II. Instead,
isolate LL16 divides the Actinobacteria I and Actinobacteria II. The bacterial isolates
that are positive for the bromoperoxidase gene fragment are highlighted in yellow and
found within all Firmicutes and Actinobacteria groups (Fig. 3). The cyanobacterium
Nostoc sp. is the out-group, and E. coli and B. cereus were included as reference type
strains.
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Figure 3. 16S rDNA Neighbor-Joining Phylogenetic Tree of Bacterial Isolates.
Positive bromoperoxidase isolates are highlighted in yellow and FADH2-dependent
halogenase isolates have an asterisk *.
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Bromoperoxidase Genetic Analysis-The genomic DNA from each bacterial isolate
was screened for a 700-bp bromoperoxidase gene fragment. Positive bromoperoxidase
fragments from bacterial isolates 8, 15, R24, and B. cereus are shown in Figure 4.
Nineteen of the 48 bacterial isolates had the 700-bp bromoperoxidase gene. Out of these
19 isolates, 16 are bacteria within the Bacillaceae family (Fig. 3). These Bacillaceae
isolates are spread between three genera. Twelve isolates are Bacillus, three are
Halobacillus, and one was identified as Paenibacillus. The remaining three isolates with
bromoperoxidase genes are Actinobacteria. They are from the genera Curtobacterium,
Rhodococcus, and Kocuria.
BLAST analyses of 19 bromoperoxidase gene fragments revealed that ten are
98% similar to a bromoperoxidase from B. cereus B4264. The ten bacterial isolates
positive for this bromoperoxidase gene are dispersed throughout the Firmicutes and
Actinobacteria groups in the phylogenetic tree (Fig. 3). Isolate WW11 is a bromatereducing bacterium with a bromoperoxidase gene fragment 96% similar to the
bromoperoxidase in B. cereus G9842. The remaining seven isolates have
bromoperoxidase gene sequences with at least 89% similarity to an arylesterase from
Bacillus thuringiensis serovar chinensis CT-43. The bromoperoxidase from isolate I37
was one of these seven isolates with 90% similarity to the arylesterase from B.
thuringiensis.
The arylesterase from isolate I37 was aligned with bromoperoxidase sequences
from Bacillus cereus G9842, Nocardiopsis dassonvillei subsp. dassonvillei DSM 43111,
and Streptomyces sp. Mg1 to compare similarity (Fig. 5). The asterisks in Figure 5 show
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the nucleotide base consensus between the four sequences. The arylesterase sequence
from isolate I37 had a 27% similarity to the bromoperoxidase from B. cereus G9842.
This was slightly higher than the 25% similarity to the bromoperoxidase from
Nocardiopsis dassonvillei subsp. dassovillei DSM 43111, and the 23% similarity to the
bromoperoxidase from Streptomyces sp. Mg1. The neighbor-joining phylogenetic tree in
Figure 6 shows that the arylesterase from isolate I37 clusters with bromoperoxidases
from the Bacillus genus in 99% of 500 replicate trees. The Bacillus bromoperoxidases
are associated with the bromoperoxidase from the brown alga, L. digitata. The bacterial
bromoperoxidases from the Streptomyces sp. and the cyanobacterium Synechococcus sp.
are related with a high bootstrap value of 100. The bacterial bromoperoxidase from N.
dassonvillei and the red algal bromoperoxidase from C. officinalis cluster together with a
bootstrap of 94.
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Figure 4. Representative Positive Bromoperoxidase Gel Isolates.
Isolates 8, 15 and R24 have a 700-bp bromoperoxidase gene fragment.
B. cereus is the positive control.
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Figure 5. Bromoperoxidase Gene Sequence Alignment Using ClustalW2.
The four aligned bromoperoxidase sequences are from Bacillus cereus G9842, Isolate I37
gene fragment, Nocardiopsis dassonvillei subsp. dassonvillei DSM 43111, and
Streptomyces sp. Mg1.
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Figure 6. Bromoperoxidase Neighbor-Joining Phylogenetic Tree.

Bromoperoxidase Activity-Eight bacterial isolates with the bromoperoxidase gene
fragment were cultured for bromoperoxidase purification. The bacterial cells were
collected and sonicated at an OD between 0.6-0.8 at 600 nm. The proteins from the
bacterial isolates were partially purified with ammonium sulfate precipitation and anionexchange chromatography. Bromoperoxidase activity was checked with a phenol red gel
assay. Protein fractions with bromoperoxidase activity in the phenol red gel assay were
tested in the MCD assay. Two bacterial isolates with bromoperoxidase activity in the
phenol red gel assay are shown in Figures 7 and 8.
The bromoperoxidase active proteins from the two isolates have different
molecular weights. The bromoperoxidase from isolate I37 has a molecular weight of
approximately 67 kDa (Fig. 7), while the bromoperoxidase from isolate HH26 has a
molecular weight of about 232 kDa (Fig. 8). The catalase in the protein ladder of Figure
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8 also shows bromoperoxidase activity and has a molecular weight of 232 kDa. The
isolates HH26, S34, T48, X36, and H46 had bromoperoxidase activity in the phenol red
gel assay, but not the MCD assay. The bromoperoxidase active proteins from these
isolates have varying molecular weights as listed in Table 5. The only isolate with
bromoperoxidase activity in both the phenol red and MCD assay was isolate I37, with a
molecular weight of 67 kDa.
Bromoperoxidase activity was found in the 0.35 M and 0.45 M NaCl fraction of
isolate I37 (Fig. 7). The 0.35M NaCl fraction of isolate I37 had a protein concentration
of 9 mg/ml based on the Bradford protein assay. The 0.35 M and 0.45 M NaCl fractions
of isolate I37 were not pure, as seen from the many different proteins depicted in the
Coomassie Blue stained gel (Fig. 7). The specific bromoperoxidase activity in the MCD
assay of the 0.35 M NaCl fraction from isolate I37 was 0.417 units. The conversion of 1
µmol of MCD in 1 min is defined as one unit (U) of enzyme activity (24). The positive
control for the MCD assay was the bromoperoxidase from the red algae Corallina
officinalis. The C. officinalis bromoperoxidase had an activity of 5 units in the MCD
assay and a molecular weight of approximately 669 kDa. The boiled bovine serum
albumin negative control did not have bromoperoxidase activity.
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Figure 7. Phenol Red Activity Gel (A) and Coomassie Blue Gel (B) of Isolate I37.
A. The bromophenol blue protein bands from the 0.35 M and 0.45 M NaCl fractions of
isolate I37 are circled along with the dark bromophenol blue band from the
bromoperoxidase of Corallina officinalis.
B. Both bromoperoxidase active enzymes from isolate I37 show an approximate
molecular weight of 67 kDa. The bromoperoxidase from Corallina officinalis has a faint
band circled around 669 kDa.
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Figure 8. Phenol Red Activity Gel (A) and Coomassie Blue Gel (B) of Isolate HH26.
A. The bromophenol blue protein bands from the catalase in the high molecular weight
ladder, the 0.45 M NaCl fraction of isolate HH26, and the bromoperoxidase of Corallina
officinalis are circled.
B. The catalases in the high molecular weight ladder and the bromoperoxidase active
enzyme from isolate HH26 have molecular weights of 232 kDa. The bromoperoxidase
from Corallina officinalis has a molecular weight around 669 kDa.

Table 5. Molecular Weights of Bromoperoxidases from Bacterial Isolates.
Isolate

Approximate weight of bromoperoxidase active
enzyme in kilo Daltons (kDa)

I37

67

HH26

232

S34

232

T48

67

X36

140

H46

232
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Bacterial Growth Curve of Isolate I37-Isolate I37 was the only isolate with
bromoperoxidase activity in both the phenol red and MCD assays. The bacterial growth
curve of isolate I37 is displayed in Figure 9. There was no lag phase in the growth of
isolate I37. The doubling time was 17.55 hours at a temperature of 25oC. The equation
ln(2)/0.0395 was used to calculate the doubling time with a growth rate=0.0395. The
growth rate is the number of doublings that occur per unit of time (26).

Figure 9. Bacterial Growth Curve of Isolate I37.

FADH2-Dependent Halogenase Genetic Analysis-The FADH2-dependent
halogenase primers from Hornung et al. amplified a 1,000-bp halogenase fragment from
isolate MM2 and X36 (18). These two isolates are indicated in Figure 3 with an asterisk.
Isolate X36 also carries the bromoperoxidase gene on its chromosomal DNA (Fig. 3).
Isolate MM2 shows similarity to a Bacillus bacterium from the Firmicutes II group, while
isolate X36 is similar to a Paenibacillaceae bacterium from the Firmicutes I group. The
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Firmicutes I group is more similar to the B. cereus group of bacteria than to the
Firmicutes II. The amplified 1,000-bp halogenase gene fragment from isolate X36 is
displayed in the electrophoresis gel in Figure 10. From a BLAST analysis, the genetic
sequence of the halogenase is 71% similar to a branched chain amino acid transport
system II carrier protein from Bacillus cereus B4264. The halogenase gene fragment
from isolate MM2 has not been sequenced yet.
For comparison purposes, the halogenases from isolate X36, Paenibacillus sp.
JDR-2, and Bacillus cereus subsp. cytotoxis NVH 391-98 were aligned using ClustalW2
(Fig. 11). Asterisks indicate nucleotide base consensus between the three aligned
halogenases (Fig. 11). The halogenases of isolate X36 and Bacillus cereus subsp.
cytotoxis NVH 391-98 have 67% similarity. The halogenase from isolate X36 is 66%
similar to the halogenase from the Paenibacillus bacterium. Both halogenases from the
Paenibacillus and Bacillus bacteria are tryptophan halogenases. A neighbor-joining
phylogenetic tree comparing halogenases from different genera and isolate X36 was
constructed with MEGA (Fig. 12). The halogenase from isolate X36 is similar to the
halogenase from Bacillus cereus subsp. cytotoxis NVH 391-98 (Fig. 12). The bootstrap
value at the node of isolates X36 and Bacillus cereus sp. is 100, which signifies that these
halogenases cluster together every time out of 500 replicate trees.
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Figure 10. FADH2-Dependent Halogenase from Isolate X36.
Isolate X36 has a 1,000-bp halogenase.
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Figure 11. FADH2-Dependent Halogenase Alignment Using ClustalW2.
FADH2-dependent halogenases from Paenibacillus sp. JDR-2, Bacillus cereus subsp.
cytotoxis NVH 391-98, and Isolate X36 were aligned with ClustalW2.
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Figure 12. FADH2-Dependent Halogenase Neighbor-Joining Phylogenetic Tree.
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Discussion
16S rDNA Phylogenetic Tree-The gram-positive bacteria from the surface of the
red-banded acorn worm Ptychodera jamaicensis belong to the Firmicutes and
Actinobacteria phyla. There were 36 Firmicutes and 12 Actinobacteria isolated from the
acorn worm examined in this study. These isolates appear to be a promising source of
natural products found in the marine environment. Bacteria from the Firmicutes and
Actinobacteria phyla are the leading producers of antibiotics. The Streptomyces
synthesize 34% of known bioactive microbial metabolites, and Bacillus species produce
around 800 antimicrobials (27). The Bacillus genus was the most prominent genus of
bacteria present on the acorn worm. Bacteria produce antimicrobials to compete with
other microorganisms in the environment. Larger organisms often form symbiotic
relationships with bacteria and accumulate these metabolites. The antibiotics produced
by epiphytic Bacillus bacteria on the sponge Ircinia fusca prevent other bacteria from
colonizing the sponge (28).
The isolates from the acorn worm are members of two distinct subgroups of the
Firmicutes and Actinobacteria phyla. The Firmicutes I and Actinobacteria I are related to
Bacillus cereus, and the Firmicutes II and Actinobacteria II are related to the
Streptomyces sp. (Fig. 3). Some of these isolates belong to novel groups. The isolate
43B is 99% similar to Nocardiopsis dassonvillei subsp. dassonvillei DSM 43111 and is
the starting node of the Actinobacteria I group. The genus Nocardiopsis represents a new
actinomycete lineage related to the Actinomadura-ThermomonosporaStreptosporangium-Microtetraspora (ATSM) group of bacteria (29). This genus belongs
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to a new family of bacteria under the name Nocardiopsaceae fam. nov. (29). These
bacteria are more similar to the B. cereus group of bacteria than to other Actinobacteria.
Bromoperoxidase Genetic Analysis-The bacteria related to the B. cereus group
(Firmicutes I and Actinobacteria I) were more likely to have the bromoperoxidase gene
fragment than those that were not related to B. cereus. Thirteen bacteria from the
Firmicutes I and Actinobacteria I groups, and six bacteria from the Firmicutes II and
Actinobacteria II groups have the bromoperoxidase gene. In total, the primers amplified
bromoperoxidase genes from 16 Firmicutes and three Actinobacteria. The
bromoperoxidase primers do not appear to be specific for Bacillus bacteria, because three
Actinobacteria were positive for the bromoperoxidase fragment. More Firmicutes were
expected to have the bromoperoxidase gene as there were 27 Bacillus isolates on the
worm.
The bromoperoxidase primers were designed from a consensus region of five
bromoperoxidases from the B. cereus group of bacteria. The Bacillus strains were
Bacillus anthracis str. “Ames Ancestor”, Bacillus cereus AH820, Bacillus cereus ATCC
10987, Bacillus cereus B4264, and Bacillus cereus G9842. The B. cereus group includes
Bacillus cereus, Bacillus anthracis, and Bacillus thuringiensis. These bacteria have high
economic, medical, and biodefense importance (30). Some argue that B. cereus, B.
thuringiensis, and B. anthracis are essentially the same, except B. cereus does not have
the plasmid producing toxins found in B. anthracis or B. thuringiensis. The Bacillus
anthracis terrorist attacks in 2001 led to the genome sequencing of these three bacteria in
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the B. cereus group. Both B. cereus and B. anthracis have bromoperoxidase genes. B.
thuringiensis has a chloroperoxidase gene.
The bromoperoxidase primers amplified 19 bromoperoxidase genes that were
closest in similarity to the B. cereus group of bromoperoxidases. Twelve of the
bromoperoxidase fragments were similar to bromoperoxidases in Bacillus cereus strains
and seven had 89% or higher similarity to arylesterases in Bacillus thuringiensis.
Arylesterases are hydrolases that act on carboxylic ester bonds. The enzymes hydrolyze
the substrate phenyl acetate to form phenol and acetate. Arylesterases share the same
catalytic triad (Ser-His-Asp) as the cofactor-free haloperoxidases in bacteria. This
catalytic triad is found in lipases, esterases, and serine proteases (31). The
bromoperoxidases from the B. cereus group of bacteria are cofactor-free haloperoxidases
or perhydrolases that belong to the diverse class of alpha/beta (α/β) hydrolase fold
enzymes. The primers did not amplify bromoperoxidases in the gram-negative E. coli or
the archaeon, M. mazei. There is no literature on bromoperoxidases isolated from either
E. coli or M. mazei, and these samples served as negative controls.
Bromoperoxidase Activity and Bacterial Growth Curve of Isolate I37-Of the eight
isolates that had the bromoperoxidase gene and were assayed for bromoperoxidase
activity, only isolate I37 had bromoperoxidase activity in the phenol red gel and MCD
assays. One reason for this observation could be that bromoperoxidase expression may
only occur at optical densities (ODs) greater than 0.6 at 600 nm. The bacterial cells from
isolate I37 were collected at an OD of 0.8, while the other isolates were grown to an OD
of 0.6. Bacterial bromoperoxidases seem to be expressed in late exponential phase, as in
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the case of the bromoperoxidase isolated and purified from the bacterium Pseudomonas
aureofaciens (32). Bacteria may need to grow to higher cell densities to reach the late
exponential phase and express the bromoperoxidase. From the growth curve of isolate
I37, it is clear that the bacteria were still in the exponential phase of the growth cycle at
an OD of 0.8. The stationary phase did not occur until an OD of 1.7 (Fig. 9). The late
exponential phase of isolate I37 may be at an OD of 1.0 and higher.
The primary role of cofactor-free bromoperoxidases in bacteria may be to
breakdown hydrogen peroxide. The bromoperoxidases may require a hydrogen peroxide
rich environment for expression (32-34). This is consistent with the observation that
there is a higher accumulation of toxic waste products, including hydrogen peroxide in
the late exponential growth phase, which may stimulate the expression of
bromoperoxidase genes. In the oceanic sediment, hydrogen peroxide in the seawater is
produced from the photochemical reduction of oxygen with dissolved organic matter and
ultraviolet light (35). The bacteria may reduce hydrogen peroxide from seawater and
produce brominated products. In the laboratory, these enzymes may not be expressed
until there is an accumulation of hydrogen peroxide.
The partially purified proteins from eight bacterial isolates positive for the
bromoperoxidase gene were tested with the phenol red gel and the monochlorodimedone
assay for bromoperoxidase activity. The phenol red gel assay is a quick and easy assay
for visualization of enzyme activity, but is not specific for bromoperoxidase activity.
Any enzyme that acts as a peroxidase or catalase can give a false positive by degrading
hydrogen peroxide, oxidizing bromide and brominating phenol red. Catalases present in
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the protein ladder can brominate phenol red and display the typical bromophenol blue
protein bands (Fig. 8). Protein fractions that showed oxygen gas formation after the
addition of hydrogen peroxide and had molecular weights close to 232 kDa were
considered catalases. The catalases in the high molecular weight protein ladder had a
molecular weight of 232 kDa. Isolates HH26, S34, and H46 had catalase active proteins
with similar molecular weights (Table 5).
There are several bacterial bromoperoxidases with catalase, and peroxidase
activity. Some of these are bromoperoxidase-catalases. Additional hydrogen peroxide
was added to the bromoperoxidase assays to ensure that catalase and peroxidase enzymes
were not depleting the hydrogen peroxide needed for halogenation reactions. The
bromoperoxidase-catalase from a Streptomyces bacterium has a molecular weight
between 127-136 kDa (33). This is unusual in that the molecular weight of most
cofactor-free bromoperoxidases is between 30-90 kDa. If the bromoperoxidase consists
of a single subunit, it usually has a molecular weight of 30 kDa. X-Ray diffraction
studies show that the bromoperoxidase from Bacillus anthracis str. “Ames Ancestor” has
three bromoperoxidase subunits, each approximately 30 kDa (36). The exception to this
is a bromoperoxidase from a Pseudomonas sp. with a molecular weight of 154 kDa (34).
Therefore, the molecular weight range targeted for these bromoperoxidases was 154 kDa
and lower. Isolates I37, T48, and X36 were within this range, but only isolate I37
showed activity in the MCD assay.
Any protein fraction that showed bromoperoxidase activity in the phenol red gel
assay was tested for confirmation with the MCD assay. Unfortunately, the MCD assay
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can also yield false positive results. The assay focuses on the decline of MCD and not on
the formation of the bromochloroindole product or any other dihalogenated dimedones.
In fact, a cytochrome c(6) protein from cyanobacteria and green algae shows
haloperoxidase activity in the MCD assay (37). Although isolate I37 has a
bromoperoxidase activity of 0.417 units in the MCD assay, it could be a cytochrome
enzyme and not a bromoperoxidase. Cytochrome c assay kits are available to test isolate
I37 for activity and rule out this possibility. Sequencing of the protein would also
confirm this. The low bromoperoxidase activity of isolate I37 in the MCD assay could be
due to the partial purity of the sample. A number of different proteins were present in
both the 0.35 M and 0.45 M NaCl eluents of isolate I37 (Fig. 7).
FADH2-Dependent Halogenase Genetic Analysis-The FADH2-dependent
halogenases are different from the haloperoxidases in that they require oxygen instead of
hydrogen peroxide and are responsible for the production of most halogenated antibiotics.
The FADH2-dependent halogenases also require a flavin reductase to produce FADH2
from FAD and NADH or NADPH. Some halogenases have conserved motifs near the
middle of the enzyme for two tryptophan residues (WxWxIP), which reflects the
enzyme’s substrate specificity for tryptophan and indole derivatives. Other halogenases
preferentially bind phenols and pyrroles. The FADH2-dependent halogenase primers
were designed from conserved regions of six FADH2-dependent halogenases specific for
phenol and pyrrole substrates in actinomycetes strains (18). These primers may help
predict the biosynthetic potential of bacterial strains.
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The FADH2-dependent halogenase primers amplified halogenase gene fragments
from two bacterial isolates on the red-banded acorn worm. This is a high frequency as
there were only 12 actinomycetes strains on the worm. Hornung et al. screened 550
actinomycetes known to produce natural products and found 103 bacterial isolates with
FADH2-dependent halogenase genes (18). Both bacterial isolates with halogenase genes
were from the Firmicutes I and Firmicutes II groups, and not the Actinobacteria (Fig. 3).
The halogenase sequence of isolate X36 is 71% similar to a branched-chain amino acid
transport system carrier protein from B. cereus. Halogenation reactions often occur on
polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) scaffolds with
substrates that are bound to carrier proteins (38). An aminoacyl-S-PCP (peptidyl carrier
protein) may be relevant for the chlorination of amino acid residues of vancomycin,
balhimycin, and other glycopeptide antibiotics (38). FADH2-dependent halogenases use
these scaffolds in reactions. The FADH2-dependent halogenase involved in the synthesis
of the antifungal pyoluterorin dichlorinates a pyrrolyl-S-carrier protein (39).
The halogenase fragment from isolate X36 is similar to amino acid transport
proteins, but also shares 66-67% similarity with tryptophan halogenases in
Paenibacillaceae and Bacillus strains (Fig. 11). The halogenases from Paenibacillaceae
sp., Bacillus sp., and isolate X36 are approximately 1,000-bp in size. The halogenase
from isolate X36 is closely related to the halogenase from Bacillus cereus subsp.
cytotoxis, as shown in the FADH2-dependent halogenase phylogenetic tree (Fig. 12).
These results are consistent with the 16S rDNA phylogenetic tree results. Isolate X36
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clustered more closely with Bacillus genera than with isolate 6, which is related to
Paenibacillus bacteria.

Summary
This study shows that 19 bacteria present on the red-banded acorn worm
Ptychodera jamaicensis have bromoperoxidase genes, and two isolates have genes
similar to the FADH2-dependent halogenases. According to the NCBI website, there are
only eight halogenase genes in the Firmicutes phyla (40). These genes synthesize
halogenation enzymes responsible for most of the halogenated antibiotics produced in
bacteria, and Bacillus bacteria are the second major producer of antibiotics. With the
large amount of Bacillus and Actinobacteria present in the oceanic sediment, these
bacteria may be capable of producing novel halogenated products. It seems that the
bacteria living on the red-banded acorn worm Ptychodera jamaicensis have the capability
to produce halogenation enzymes. Furthermore, the bacterial isolate I37 is a Bacillus
with a bromoperoxidase active enzyme that brominates phenol red and
monochlorodimedone.
Bacteria living on acorn worms appear to contribute to the production of
bromophenols present on the worms. These compounds may act as antibiotics that ward
off gram-negative bacteria from settling on the worm and within its burrows, which may
explain why only gram-positive bacteria were isolated from the red-banded acorn worm.
Brominated compounds produced by algae can disrupt the growth of gram-negative
bacterial biofilms (41). The organohalogens may also aid the acorn worm as chemical
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deterrents, and chemical substrates in bioluminescent reactions (42, 43-45). There
appears to be a mutualistic relationship between marine acorn worms and bacteria. There
are many examples of bacteria forming commensal and mutualistic relationships with
marine worms. For example, bacteria in the integument of the marine worm Urechis
caupo may metabolize toxic hydrogen sulfide produced in the hypoxic worm burrows at
low tide (46). The hydrothermal vent worm Riftia pachyptila, also uses commensal
bacteria to digest noxious materials it ingests (47).
The ocean is a logical place to search for new bacteria and halogenated products.
The Proteobacteria, Bacteroidetes, Fusobacteria, Actinobacteria, and Firmicutes are
among the phyla found within the oceanic sediment, but there is much bacterial diversity
that remains to be discovered (48). Gontang, Fenical, and Jensen isolated bacteria from
intertidal sediments to depths of 500 meters and found that 37.2% of operational
taxonomic units likely represent new taxa and the remainder belonged to the
Actinobacteria and Firmicutes phyla (49). These bacteria are a significant source of
natural products and may be found living in symbiotic relationships with other marine
organisms.
This study is ongoing and 35 bacterial isolates remain to be screened for
bromoperoxidase active proteins. Future research includes conducting mass
spectrophotometric scans of the culture supernatant of isolate X36 and I37 for
bromophenols and other halogenated organics. The bromoperoxidase active isolate from
I37 will be assayed for cytochrome c(6) activity and the protein sequenced for
identification. SDS-PAGE gels can show if the bromoperoxidase active enzyme of
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isolate I37 is 67 kDa, or if it is composed of monomer polypeptide subunits. Isolation
and characterization of these enzymes have the potential to support the large scale
production of future antibiotics, antitumor agents, and catalysts in green chemistry
processes.
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